Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact Questionnaire

Abstract Background Capturing the impact of caring for patients with debilitating rare disease is important for understanding disease burden. We aimed to develop and validate an instrument to measure the impact on caregivers of caring for children with three lysosomal storage diseases (LSDs): metach...

Full description

Saved in:
Bibliographic Details
Main Authors: Magdalena Harrington (Author), Asha Hareendran (Author), Anne Skalicky (Author), Hilary Wilson (Author), Marci Clark (Author), Jaromir Mikl (Author)
Format: Book
Published: SpringerOpen, 2019-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_dbf688b2323b48aca9cb9a7be9c2f38c
042 |a dc 
100 1 0 |a Magdalena Harrington  |e author 
700 1 0 |a Asha Hareendran  |e author 
700 1 0 |a Anne Skalicky  |e author 
700 1 0 |a Hilary Wilson  |e author 
700 1 0 |a Marci Clark  |e author 
700 1 0 |a Jaromir Mikl  |e author 
245 0 0 |a Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact Questionnaire 
260 |b SpringerOpen,   |c 2019-07-01T00:00:00Z. 
500 |a 10.1186/s41687-019-0140-3 
500 |a 2509-8020 
520 |a Abstract Background Capturing the impact of caring for patients with debilitating rare disease is important for understanding disease burden. We aimed to develop and validate an instrument to measure the impact on caregivers of caring for children with three lysosomal storage diseases (LSDs): metachromatic leukodystrophy (MLD), neuronopathic mucopolysaccharidosis type II (MPS II) and mucopolysaccharidosis type IIIA (MPS IIIA). Methods A draft instrument was developed based on targeted literature searches and revised through sequential qualitative interviews with caregivers of patients first with MLD (n = 16), then with MPS II (n = 22), and finally with MPS IIIA (n = 8). The instrument, which covered domains of physical, emotional, social and economic burden, was refined at each stage of development based on caregiver feedback. Saturation of major concepts was reached during concept elicitation (MLD and MPS II). Results It was confirmed that caring for a patient with an LSD impacts social functioning, emotional/psychological functioning, physical functioning, daily activities, and finances/work productivity. Results from cognitive debriefing of the draft questionnaires were considered during each round of interviews, resulting in a final set of items that caregivers found clear and easy to understand. The Caregiver Impact Questionnaire (CIQ) has 30 items in five domains: (1) social functioning (7 items); (2) impact on daily activities (5 items); (3) emotional/psychological functioning (10 items); (4) physical functioning (6 items); and (5) financial impact (2 items). Conclusions These findings demonstrate that the content of the CIQ is relevant for determining the impact of caring on caregivers of patients with MLD, MPS II and MPS IIIA. 
546 |a EN 
690 |a Caregiver questionnaire 
690 |a Lysosomal storage disease 
690 |a Metachromatic leukodystrophy 
690 |a MLD 
690 |a MPS II 
690 |a MPS IIIA 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-14 (2019) 
787 0 |n http://link.springer.com/article/10.1186/s41687-019-0140-3 
787 0 |n https://doaj.org/toc/2509-8020 
856 4 1 |u https://doaj.org/article/dbf688b2323b48aca9cb9a7be9c2f38c  |z Connect to this object online.